Comparing single and cumulative dosing procedures in human triazolam discriminators

Area of Science:

• Pharmacology
• Behavioral Neuroscience
• Human Subject Research

Background:

• Drug discrimination studies are crucial for understanding psychoactive substance effects.
• Traditional methods involve single dosing, which can be time-consuming.
• Evaluating alternative dosing procedures like cumulative dosing is essential for research efficiency.

Purpose of the Study:

• To evaluate a cumulative dosing procedure for drug discrimination in human participants.
• To compare the efficiency and outcomes of cumulative dosing versus single dosing.
• To assess the discriminative stimulus and self-reported effects of triazolam and secobarbital.

Main Methods:

• A crossover design was employed with four human participants.
• Participants learned to discriminate triazolam from placebo.
• Drug effects were assessed under both single and cumulative dosing procedures for triazolam and secobarbital.

Main Results:

• Both triazolam and secobarbital produced effects consistent with previous single dosing studies.
• Cumulative dosing yielded dose-effect curves comparable to single dosing.
• Rightward shifts in cumulative dose-effect curves were observed on some self-report measures.

Conclusions:

• Cumulative dosing is an efficient method for generating dose-effect curves in human drug discrimination studies.
• This procedure is particularly valuable when qualitative stimulus functions are of primary interest.
• Cumulative dosing offers a more streamlined approach to human psychopharmacological research.